1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Rectal Cancer Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Medicine 1.2.3 Surgery 1.2.4 Other 1.3 Market by Application 1.3.1 Global Rectal Cancer Therapeutics Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Rectal Cancer Therapeutics Market Perspective (2016-2027) 2.2 Rectal Cancer Therapeutics Growth Trends by Regions 2.2.1 Rectal Cancer Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Rectal Cancer Therapeutics Historic Market Share by Regions (2016-2021) 2.2.3 Rectal Cancer Therapeutics Forecasted Market Size by Regions (2022-2027) 2.3 Rectal Cancer Therapeutics Industry Dynamic 2.3.1 Rectal Cancer Therapeutics Market Trends 2.3.2 Rectal Cancer Therapeutics Market Drivers 2.3.3 Rectal Cancer Therapeutics Market Challenges 2.3.4 Rectal Cancer Therapeutics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Rectal Cancer Therapeutics Players by Revenue 3.1.1 Global Top Rectal Cancer Therapeutics Players by Revenue (2016-2021) 3.1.2 Global Rectal Cancer Therapeutics Revenue Market Share by Players (2016-2021) 3.2 Global Rectal Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Rectal Cancer Therapeutics Revenue 3.4 Global Rectal Cancer Therapeutics Market Concentration Ratio 3.4.1 Global Rectal Cancer Therapeutics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Rectal Cancer Therapeutics Revenue in 2020 3.5 Rectal Cancer Therapeutics Key Players Head office and Area Served 3.6 Key Players Rectal Cancer Therapeutics Product Solution and Service 3.7 Date of Enter into Rectal Cancer Therapeutics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Rectal Cancer Therapeutics Breakdown Data by Type 4.1 Global Rectal Cancer Therapeutics Historic Market Size by Type (2016-2021) 4.2 Global Rectal Cancer Therapeutics Forecasted Market Size by Type (2022-2027) 5 Rectal Cancer Therapeutics Breakdown Data by Application 5.1 Global Rectal Cancer Therapeutics Historic Market Size by Application (2016-2021) 5.2 Global Rectal Cancer Therapeutics Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Rectal Cancer Therapeutics Market Size (2016-2027) 6.2 North America Rectal Cancer Therapeutics Market Size by Type 6.2.1 North America Rectal Cancer Therapeutics Market Size by Type (2016-2021) 6.2.2 North America Rectal Cancer Therapeutics Market Size by Type (2022-2027) 6.2.3 North America Rectal Cancer Therapeutics Market Size by Type (2016-2027) 6.3 North America Rectal Cancer Therapeutics Market Size by Application 6.3.1 North America Rectal Cancer Therapeutics Market Size by Application (2016-2021) 6.3.2 North America Rectal Cancer Therapeutics Market Size by Application (2022-2027) 6.3.3 North America Rectal Cancer Therapeutics Market Size by Application (2016-2027) 6.4 North America Rectal Cancer Therapeutics Market Size by Country 6.4.1 North America Rectal Cancer Therapeutics Market Size by Country (2016-2021) 6.4.2 North America Rectal Cancer Therapeutics Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Rectal Cancer Therapeutics Market Size (2016-2027) 7.2 Europe Rectal Cancer Therapeutics Market Size by Type 7.2.1 Europe Rectal Cancer Therapeutics Market Size by Type (2016-2021) 7.2.2 Europe Rectal Cancer Therapeutics Market Size by Type (2022-2027) 7.2.3 Europe Rectal Cancer Therapeutics Market Size by Type (2016-2027) 7.3 Europe Rectal Cancer Therapeutics Market Size by Application 7.3.1 Europe Rectal Cancer Therapeutics Market Size by Application (2016-2021) 7.3.2 Europe Rectal Cancer Therapeutics Market Size by Application (2022-2027) 7.3.3 Europe Rectal Cancer Therapeutics Market Size by Application (2016-2027) 7.4 Europe Rectal Cancer Therapeutics Market Size by Country 7.4.1 Europe Rectal Cancer Therapeutics Market Size by Country (2016-2021) 7.4.2 Europe Rectal Cancer Therapeutics Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Rectal Cancer Therapeutics Market Size (2016-2027) 8.2 Asia-Pacific Rectal Cancer Therapeutics Market Size by Type 8.2.1 Asia-Pacific Rectal Cancer Therapeutics Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Rectal Cancer Therapeutics Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Rectal Cancer Therapeutics Market Size by Type (2016-2027) 8.3 Asia-Pacific Rectal Cancer Therapeutics Market Size by Application 8.3.1 Asia-Pacific Rectal Cancer Therapeutics Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Rectal Cancer Therapeutics Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Rectal Cancer Therapeutics Market Size by Application (2016-2027) 8.4 Asia-Pacific Rectal Cancer Therapeutics Market Size by Region 8.4.1 Asia-Pacific Rectal Cancer Therapeutics Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Rectal Cancer Therapeutics Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Rectal Cancer Therapeutics Market Size (2016-2027) 9.2 Latin America Rectal Cancer Therapeutics Market Size by Type 9.2.1 Latin America Rectal Cancer Therapeutics Market Size by Type (2016-2021) 9.2.2 Latin America Rectal Cancer Therapeutics Market Size by Type (2022-2027) 9.2.3 Latin America Rectal Cancer Therapeutics Market Size by Type (2016-2027) 9.3 Latin America Rectal Cancer Therapeutics Market Size by Application 9.3.1 Latin America Rectal Cancer Therapeutics Market Size by Application (2016-2021) 9.3.2 Latin America Rectal Cancer Therapeutics Market Size by Application (2022-2027) 9.3.3 Latin America Rectal Cancer Therapeutics Market Size by Application (2016-2027) 9.4 Latin America Rectal Cancer Therapeutics Market Size by Country 9.4.1 Latin America Rectal Cancer Therapeutics Market Size by Country (2016-2021) 9.4.2 Latin America Rectal Cancer Therapeutics Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Rectal Cancer Therapeutics Market Size (2016-2027) 10.2 Middle East & Africa Rectal Cancer Therapeutics Market Size by Type 10.2.1 Middle East & Africa Rectal Cancer Therapeutics Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Rectal Cancer Therapeutics Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Rectal Cancer Therapeutics Market Size by Type (2016-2027) 10.3 Middle East & Africa Rectal Cancer Therapeutics Market Size by Application 10.3.1 Middle East & Africa Rectal Cancer Therapeutics Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Rectal Cancer Therapeutics Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Rectal Cancer Therapeutics Market Size by Application (2016-2027) 10.4 Middle East & Africa Rectal Cancer Therapeutics Market Size by Country 10.4.1 Middle East & Africa Rectal Cancer Therapeutics Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Rectal Cancer Therapeutics Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Eli Lilly and Company 11.1.1 Eli Lilly and Company Company Details 11.1.2 Eli Lilly and Company Business Overview 11.1.3 Eli Lilly and Company Rectal Cancer Therapeutics Introduction 11.1.4 Eli Lilly and Company Revenue in Rectal Cancer Therapeutics Business (2016-2021) 11.1.5 Eli Lilly and Company Recent Development 11.2 Taiwan Liposome 11.2.1 Taiwan Liposome Company Details 11.2.2 Taiwan Liposome Business Overview 11.2.3 Taiwan Liposome Rectal Cancer Therapeutics Introduction 11.2.4 Taiwan Liposome Revenue in Rectal Cancer Therapeutics Business (2016-2021) 11.2.5 Taiwan Liposome Recent Development 11.3 Genentech 11.3.1 Genentech Company Details 11.3.2 Genentech Business Overview 11.3.3 Genentech Rectal Cancer Therapeutics Introduction 11.3.4 Genentech Revenue in Rectal Cancer Therapeutics Business (2016-2021) 11.3.5 Genentech Recent Development 11.4 Sanofi-aventis Groupe 11.4.1 Sanofi-aventis Groupe Company Details 11.4.2 Sanofi-aventis Groupe Business Overview 11.4.3 Sanofi-aventis Groupe Rectal Cancer Therapeutics Introduction 11.4.4 Sanofi-aventis Groupe Revenue in Rectal Cancer Therapeutics Business (2016-2021) 11.4.5 Sanofi-aventis Groupe Recent Development 11.5 Merck 11.5.1 Merck Company Details 11.5.2 Merck Business Overview 11.5.3 Merck Rectal Cancer Therapeutics Introduction 11.5.4 Merck Revenue in Rectal Cancer Therapeutics Business (2016-2021) 11.5.5 Merck Recent Development 11.6 Bristol-Myers Squibb 11.6.1 Bristol-Myers Squibb Company Details 11.6.2 Bristol-Myers Squibb Business Overview 11.6.3 Bristol-Myers Squibb Rectal Cancer Therapeutics Introduction 11.6.4 Bristol-Myers Squibb Revenue in Rectal Cancer Therapeutics Business (2016-2021) 11.6.5 Bristol-Myers Squibb Recent Development 11.7 Hutchison MediPharma 11.7.1 Hutchison MediPharma Company Details 11.7.2 Hutchison MediPharma Business Overview 11.7.3 Hutchison MediPharma Rectal Cancer Therapeutics Introduction 11.7.4 Hutchison MediPharma Revenue in Rectal Cancer Therapeutics Business (2016-2021) 11.7.5 Hutchison MediPharma Recent Development 11.8 Seattle Genetics 11.8.1 Seattle Genetics Company Details 11.8.2 Seattle Genetics Business Overview 11.8.3 Seattle Genetics Rectal Cancer Therapeutics Introduction 11.8.4 Seattle Genetics Revenue in Rectal Cancer Therapeutics Business (2016-2021) 11.8.5 Seattle Genetics Recent Development 11.9 Advaxis 11.9.1 Advaxis Company Details 11.9.2 Advaxis Business Overview 11.9.3 Advaxis Rectal Cancer Therapeutics Introduction 11.9.4 Advaxis Revenue in Rectal Cancer Therapeutics Business (2016-2021) 11.9.5 Advaxis Recent Development 11.10 Pfizer 11.10.1 Pfizer Company Details 11.10.2 Pfizer Business Overview 11.10.3 Pfizer Rectal Cancer Therapeutics Introduction 11.10.4 Pfizer Revenue in Rectal Cancer Therapeutics Business (2016-2021) 11.10.5 Pfizer Recent Development 11.11 AstraZeneca 11.11.1 AstraZeneca Company Details 11.11.2 AstraZeneca Business Overview 11.11.3 AstraZeneca Rectal Cancer Therapeutics Introduction 11.11.4 AstraZeneca Revenue in Rectal Cancer Therapeutics Business (2016-2021) 11.11.5 AstraZeneca Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Rectal Cancer Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Medicine Table 3. Key Players of Surgery Table 4. Key Players of Other Table 5. Global Rectal Cancer Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Rectal Cancer Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Rectal Cancer Therapeutics Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Rectal Cancer Therapeutics Market Share by Regions (2016-2021) Table 9. Global Rectal Cancer Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Rectal Cancer Therapeutics Market Share by Regions (2022-2027) Table 11. Rectal Cancer Therapeutics Market Trends Table 12. Rectal Cancer Therapeutics Market Drivers Table 13. Rectal Cancer Therapeutics Market Challenges Table 14. Rectal Cancer Therapeutics Market Restraints Table 15. Global Rectal Cancer Therapeutics Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Rectal Cancer Therapeutics Market Share by Players (2016-2021) Table 17. Global Top Rectal Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rectal Cancer Therapeutics as of 2020) Table 18. Ranking of Global Top Rectal Cancer Therapeutics Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Rectal Cancer Therapeutics Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Rectal Cancer Therapeutics Product Solution and Service Table 22. Date of Enter into Rectal Cancer Therapeutics Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Rectal Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 25. Global Rectal Cancer Therapeutics Revenue Market Share by Type (2016-2021) Table 26. Global Rectal Cancer Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Rectal Cancer Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Rectal Cancer Therapeutics Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Rectal Cancer Therapeutics Revenue Market Share by Application (2016-2021) Table 30. Global Rectal Cancer Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Rectal Cancer Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Rectal Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 33. North America Rectal Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Rectal Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 35. North America Rectal Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Rectal Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Rectal Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Rectal Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Rectal Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Rectal Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Rectal Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Rectal Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Rectal Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Rectal Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Rectal Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Rectal Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Rectal Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Rectal Cancer Therapeutics Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Rectal Cancer Therapeutics Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Rectal Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Rectal Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Rectal Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Rectal Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Rectal Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Rectal Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Rectal Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Rectal Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Rectal Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Rectal Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Rectal Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Rectal Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 62. Eli Lilly and Company Company Details Table 63. Eli Lilly and Company Business Overview Table 64. Eli Lilly and Company Rectal Cancer Therapeutics Product Table 65. Eli Lilly and Company Revenue in Rectal Cancer Therapeutics Business (2016-2021) & (US$ Million) Table 66. Eli Lilly and Company Recent Development Table 67. Taiwan Liposome Company Details Table 68. Taiwan Liposome Business Overview Table 69. Taiwan Liposome Rectal Cancer Therapeutics Product Table 70. Taiwan Liposome Revenue in Rectal Cancer Therapeutics Business (2016-2021) & (US$ Million) Table 71. Taiwan Liposome Recent Development Table 72. Genentech Company Details Table 73. Genentech Business Overview Table 74. Genentech Rectal Cancer Therapeutics Product Table 75. Genentech Revenue in Rectal Cancer Therapeutics Business (2016-2021) & (US$ Million) Table 76. Genentech Recent Development Table 77. Sanofi-aventis Groupe Company Details Table 78. Sanofi-aventis Groupe Business Overview Table 79. Sanofi-aventis Groupe Rectal Cancer Therapeutics Product Table 80. Sanofi-aventis Groupe Revenue in Rectal Cancer Therapeutics Business (2016-2021) & (US$ Million) Table 81. Sanofi-aventis Groupe Recent Development Table 82. Merck Company Details Table 83. Merck Business Overview Table 84. Merck Rectal Cancer Therapeutics Product Table 85. Merck Revenue in Rectal Cancer Therapeutics Business (2016-2021) & (US$ Million) Table 86. Merck Recent Development Table 87. Bristol-Myers Squibb Company Details Table 88. Bristol-Myers Squibb Business Overview Table 89. Bristol-Myers Squibb Rectal Cancer Therapeutics Product Table 90. Bristol-Myers Squibb Revenue in Rectal Cancer Therapeutics Business (2016-2021) & (US$ Million) Table 91. Bristol-Myers Squibb Recent Development Table 92. Hutchison MediPharma Company Details Table 93. Hutchison MediPharma Business Overview Table 94. Hutchison MediPharma Rectal Cancer Therapeutics Product Table 95. Hutchison MediPharma Revenue in Rectal Cancer Therapeutics Business (2016-2021) & (US$ Million) Table 96. Hutchison MediPharma Recent Development Table 97. Seattle Genetics Company Details Table 98. Seattle Genetics Business Overview Table 99. Seattle Genetics Revenue in Rectal Cancer Therapeutics Business (2016-2021) & (US$ Million) Table 100. Seattle Genetics Recent Development Table 101. Advaxis Company Details Table 102. Advaxis Business Overview Table 103. Advaxis Rectal Cancer Therapeutics Product Table 104. Advaxis Revenue in Rectal Cancer Therapeutics Business (2016-2021) & (US$ Million) Table 105. Advaxis Recent Development Table 106. Pfizer Company Details Table 107. Pfizer Business Overview Table 108. Pfizer Rectal Cancer Therapeutics Product Table 109. Pfizer Revenue in Rectal Cancer Therapeutics Business (2016-2021) & (US$ Million) Table 110. Pfizer Recent Development Table 111. AstraZeneca Company Details Table 112. AstraZeneca Business Overview Table 113. AstraZeneca Rectal Cancer Therapeutics Product Table 114. AstraZeneca Revenue in Rectal Cancer Therapeutics Business (2016-2021) & (US$ Million) Table 115. AstraZeneca Recent Development Table 116. Research Programs/Design for This Report Table 117. Key Data Information from Secondary Sources Table 118. Key Data Information from Primary Sources List of Figures Figure 1. Global Rectal Cancer Therapeutics Market Share by Type: 2020 VS 2027 Figure 2. Medicine Features Figure 3. Surgery Features Figure 4. Other Features Figure 5. Global Rectal Cancer Therapeutics Market Share by Application: 2020 VS 2027 Figure 6. Hospital Case Studies Figure 7. Clinic Case Studies Figure 8. Other Case Studies Figure 9. Rectal Cancer Therapeutics Report Years Considered Figure 10. Global Rectal Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global Rectal Cancer Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Rectal Cancer Therapeutics Market Share by Regions: 2020 VS 2027 Figure 13. Global Rectal Cancer Therapeutics Market Share by Regions (2022-2027) Figure 14. Global Rectal Cancer Therapeutics Market Share by Players in 2020 Figure 15. Global Top Rectal Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rectal Cancer Therapeutics as of 2020 Figure 16. The Top 10 and 5 Players Market Share by Rectal Cancer Therapeutics Revenue in 2020 Figure 17. Global Rectal Cancer Therapeutics Revenue Market Share by Type (2016-2021) Figure 18. Global Rectal Cancer Therapeutics Revenue Market Share by Type (2022-2027) Figure 19. North America Rectal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America Rectal Cancer Therapeutics Market Share by Type (2016-2027) Figure 21. North America Rectal Cancer Therapeutics Market Share by Application (2016-2027) Figure 22. North America Rectal Cancer Therapeutics Market Share by Country (2016-2027) Figure 23. United States Rectal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada Rectal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Rectal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Rectal Cancer Therapeutics Market Share by Type (2016-2027) Figure 27. Europe Rectal Cancer Therapeutics Market Share by Application (2016-2027) Figure 28. Europe Rectal Cancer Therapeutics Market Share by Country (2016-2027) Figure 29. Germany Rectal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France Rectal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. Rectal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy Rectal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia Rectal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic Rectal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Rectal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Rectal Cancer Therapeutics Market Share by Type (2016-2027) Figure 37. Asia-Pacific Rectal Cancer Therapeutics Market Share by Application (2016-2027) Figure 38. Asia-Pacific Rectal Cancer Therapeutics Market Share by Region (2016-2027) Figure 39. China Rectal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan Rectal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea Rectal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia Rectal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India Rectal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia Rectal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Rectal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Rectal Cancer Therapeutics Market Share by Type (2016-2027) Figure 47. Latin America Rectal Cancer Therapeutics Market Share by Application (2016-2027) Figure 48. Latin America Rectal Cancer Therapeutics Market Share by Country (2016-2027) Figure 49. Mexico Rectal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil Rectal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Rectal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Rectal Cancer Therapeutics Market Share by Type (2016-2027) Figure 53. Middle East & Africa Rectal Cancer Therapeutics Market Share by Application (2016-2027) Figure 54. Middle East & Africa Rectal Cancer Therapeutics Market Share by Country (2016-2027) Figure 55. Turkey Rectal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia Rectal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE Rectal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Eli Lilly and Company Revenue Growth Rate in Rectal Cancer Therapeutics Business (2016-2021) Figure 59. Taiwan Liposome Revenue Growth Rate in Rectal Cancer Therapeutics Business (2016-2021) Figure 60. Genentech Revenue Growth Rate in Rectal Cancer Therapeutics Business (2016-2021) Figure 61. Sanofi-aventis Groupe Revenue Growth Rate in Rectal Cancer Therapeutics Business (2016-2021) Figure 62. Merck Revenue Growth Rate in Rectal Cancer Therapeutics Business (2016-2021) Figure 63. Bristol-Myers Squibb Revenue Growth Rate in Rectal Cancer Therapeutics Business (2016-2021) Figure 64. Hutchison MediPharma Revenue Growth Rate in Rectal Cancer Therapeutics Business (2016-2021) Figure 65. Seattle Genetics Revenue Growth Rate in Rectal Cancer Therapeutics Business (2016-2021) Figure 66. Advaxis Revenue Growth Rate in Rectal Cancer Therapeutics Business (2016-2021) Figure 67. Pfizer Revenue Growth Rate in Rectal Cancer Therapeutics Business (2016-2021) Figure 68. AstraZeneca Revenue Growth Rate in Rectal Cancer Therapeutics Business (2016-2021) Figure 69. Bottom-up and Top-down Approaches for This Report Figure 70. Data Triangulation Figure 71. Key Executives Interviewed

Eli Lilly and Company Taiwan Liposome Genentech Sanofi-aventis Groupe Merck Bristol-Myers Squibb Hutchison MediPharma Seattle Genetics Advaxis Pfizer AstraZeneca